New technologies are also a contributing factor to the market surge. Technological advances such as three- and four-dimensional (3D/4D) real-time imaging enable easier detection of high-risk pregnancies and fetal abnormalities. As a result, the OB/GYN ultrasound market accounted for more than one-quarter of the total European women's health market in 2010.
Another growing market is in transcervical female sterilization, which is forecast to grow rapidly and reach double-digit rates by 2017. This is due to reimbursement policies, which are being implemented in many European countries.
Related Links:
iData Research

.gif)
























